Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial

MN Kosiborod, R Esterline, RHM Furtado… - The lancet Diabetes & …, 2021 - thelancet.com
Background COVID-19 can lead to multiorgan failure. Dapagliflozin, a SGLT2 inhibitor, has
significant protective benefits for the heart and kidney. We aimed to see whether this agent …

[HTML][HTML] Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer …

P Grivas, AR Khaki, TM Wise-Draper, B French… - Annals of oncology, 2021 - Elsevier
Background Patients with cancer may be at high risk of adverse outcomes from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of …

The National COVID Cohort Collaborative (N3C): rationale, design, infrastructure, and deployment

MA Haendel, CG Chute, TD Bennett… - Journal of the …, 2021 - academic.oup.com
Abstract Objective Coronavirus disease 2019 (COVID-19) poses societal challenges that
require expeditious data and knowledge sharing. Though organizational clinical data are …

Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland

SJ McGurnaghan, A Weir, J Bishop… - The lancet Diabetes & …, 2021 - thelancet.com
Background We aimed to ascertain the cumulative risk of fatal or critical care unit-treated
COVID-19 in people with diabetes and compare it with that of people without diabetes, and …

Ivermectin for preventing and treating COVID‐19

M Popp, M Stegemann, MI Metzendorf… - Cochrane Database …, 2021 - cochranelibrary.com
Background Ivermectin, an antiparasitic agent used to treat parasitic infestations, inhibits the
replication of viruses in vitro. The molecular hypothesis of ivermectin's antiviral mode of …

Changes in risk perception and self-reported protective behaviour during the first week of the COVID-19 pandemic in the United States

T Wise, TD Zbozinek, G Michelini… - Royal Society …, 2020 - royalsocietypublishing.org
Efforts to change behaviour are critical in minimizing the spread of highly transmissible
pandemics such as COVID-19. However, it is unclear whether individuals are aware of …

Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European …

S Cesaro, P Ljungman, M Mikulska, HH Hirsch… - Leukemia, 2022 - nature.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a novel virus that spread
worldwide from 2019 causing the Coronavirus disease 19 (COVID-19) pandemic. SARS …

Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study

KE Mansfield, R Mathur, J Tazare… - The Lancet Digital …, 2021 - thelancet.com
Background There are concerns that the response to the COVID-19 pandemic in the UK
might have worsened physical and mental health, and reduced use of health services …

Prognostic factors for severity and mortality in patients infected with COVID-19: A systematic review

A Izcovich, MA Ragusa, F Tortosa, MA Lavena Marzio… - PloS one, 2020 - journals.plos.org
Background and purpose The objective of our systematic review is to identify prognostic
factors that may be used in decision-making related to the care of patients infected with …

Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults

EJ Anderson, NG Rouphael, AT Widge… - … England Journal of …, 2020 - Mass Medical Soc
Background Testing of vaccine candidates to prevent infection with severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased …